Home/ Supplements/ Electrolytes/ Citracal Calcium + D Slow Release 1200

Citracal Calcium + D Slow Release 1200

product on market Tablet or Pill Bayer Citacal Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 50% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

Calcium and vitamin D are supported by strong evidence for maintaining bone density and skeletal health. Magnesium and sodium serve as essential electrolytes for nerve and muscle function. However, overall evidence coverage for this specific formulation is limited.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Citracal Calcium + D Slow Release 1200
Open Full PDF View on NIH DSLD →
Details

Label Data

2 Tablet(s)
Serving Size
40
Servings
Other Combinations
Product Type
50%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

1000 IU (250% DV)
1.7× RDA — within safe limits 608 studies (A:16, B:251)
Calcium
1200 mg (120% DV)
80 mg (20% DV)
Within RDA (0.2× RDA) 316 studies (A:8, B:159)
Sodium
5 mg (1% DV)

Other Ingredients

Calcium Carbonate Calcium Citrate Magnesium Hydroxide Acacia Hydroxypropyl Methylcellulose Croscarmellose Sodium Magnesium Silicate Titanium Dioxide Propylene Glycol Dicaprylate/Dicaprate Magnesium Stearate Inulin Vitamin D3
Claims

Label Claims — Verification

Unverified All Other
Info

Product Information

Directions for Use

Take just once daily

Directions: Adults: Take 2 tablets once daily with food in the morning.

Warnings & Precautions

If pregnant or breast-feeding, ask a health professional before use.

KEEP OUT OF REACH OF CHILDREN

Due to the sustained release nature of this product, you should seek adivce from your pharmacist about use with certain prescription medications.

Do not use if printed foil seal is torn or missing.

Formulation Notes

1200 mg of calcium plus 1000 IU of vitamin D3

Additional Information

SLO-CAL(TM) TECHNOLOGY

Slowly & continuously releases calcium for efficient absorption

L082880R1009

EXPIRATION DATE:

Bayer

Bayer Bayer

Metadata

Product Details

DSLD Entry Date2012-08-24
Product TypeOther Combinations
FormTablet or Pill
DSLD ID12003
Data Updated2026-04-11
Research

Research Evidence

849
Research Sources
56
Avg Quality
450
Meta Analysis
152
Rct
137
Systematic Review
73
Clinical Trial
11
Regulatory Source
7
Other
7
Guideline
3
Openfda Safety
2
Cochrane Review
2
Observational
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
A Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps
Systematic Review The Cochrane database of systematic reviews 2008 PubMed DOI
A Calcium and vitamin D for increasing bone mineral density in premenopausal women
Systematic Review The Cochrane database of systematic reviews 2023 PubMed DOI
A Dietary sodium, sodium-to-potassium ratio, and risk of stroke: A systematic review and nonlinear dose-response meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2019 PubMed DOI
A The association between circulating magnesium and clinically relevant outcomes in patients with chronic kidney disease: A systematic review and meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2021 PubMed DOI
A Calcium channel blockers versus other classes of drugs for hypertension
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
View all evidence for Electrolytes →
Compare

Similar Products

View all Electrolytes products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.